The study has been published in the New England Journal of Medicine. This trial was conducted by a consortium of international research teams involving Inserm and the national institutes of health, as part of a partnership between researchers, Guinean authorities and NGOs.
Large study spotlights limits of HIV treatment as prevention.The study, called Treatment as Prevention (TasP), began in 2012 and enrolled 28,000 people in KwaZulu-Natal, the hardest hit province in South Africa. Sponsored by the French national research agency known as ANRS, TasP tested participants in 22 separate communities, which each had an HIV prevalence of […]
Researchers from the HEALTHY (Health, well-being and achievement in the young) team of the Bordeaux Population Health research center (BPH) found an association between headaches and tinnitus, in a study led on 5729 students from the i-Share cohort. With a mean age of 20.8 years, 1645 participants reported migraine. They were 8,9% to report tinnitus. […]
In the article published in the BMJ of may 2016, Francesco Salvo, researcher in the team “Pharmacoepidemiology and population impact of drugs” in the Bordeaux population health research center U1219, recalls the importance of compliance with recommendations regarding dipeptyl peptidase-4 inhibitors (DPP-4) and sulphonylureas when these drugs are associated in diabetics patients,. This article allows […]
A new path is opened to detect efficiently and rapidly tuberculosis in HIV-infected children. The Xpert® MTB/RIF[1] molecular test, already shown to be efficient for tuberculosis detection in HIV seropositive adults, was evaluated in a prospective cohort study of HIV-positive children aged below 14 years (ANRS 12229 PAANTHER Study). This study, undertaken by a researcher […]
In the context of the 3C study (http://www.three-city-study.com), the Bordeaux population Health research center is involved in two major international studies on the rising levels of obesity and diabetes in the world, published on April, 2nd and 9th in the Lancet, and massively carried in the media. For each study, respectively based on 19.2 millions […]
The combined issue of dementia and age-related hearing and vision problems is to be tackled by a consortium headed by The University of Manchester. The SENSE-Cog project involves, among others, Cécile Delcourt (LEHA – team leader in the BPH Research Center) as the leader of the Bordeaux campus project, the EUCLID platform as the leader […]
Despite the concern of an explosion of dementia cases in an aging population over the next few decades, a new study, based on data from the Framingham Heart Study* (FHS), and carried out in collaboration between Inserm researchers at the Bordeaux School of Public Health / Inserm in France and Boston University School of Medicine […]
Rodolphe Thiebaut,deputy director oh the research center U897 and director of the team SISTM, is the coordinator of the EBOVAC2 project, which launches its recruiting campain on the 8th of december. The project, a collaborative effort, funded under a grant from the Innovative Medicines Initiative Ebola+ programme. EBOVAC2 was launched in response to the Ebola […]
11th Canceropole day : 5th and 6th novembre 2015. Annual meeting for researchers and clinicians to meet and discuss about the different programms of the Canceropole. On the friday 6th novembre in the afternoon (02:00 pm), the team « Cancer and environmental exposures » from the research Center « Epidemiology and Biostatistics » will lead a conference about « Environmental […]
From the 28th of September to the 2nd of October, Bordeaux welcomes “Neurepiomics”, the first summer school about neuroepidemiology in the “omics” era. Organised by Pr. Stephanie Debette, research director at the center, and Pr. Christophe Tzourio, head of the research center, this first edition is designed in close partnership with Pr. Sudha Seshadri, from […]
A team from the Research center Inserm U897 “Epidemiology and biostatistics” based in Bordeaux – France set out to determine the association between use of lipid lowering drugs (statins or fribates) in healthy older people and long term risk of coronary heart disease and stroke. The BMJ (British medicine journal) published a press release about […]
Cholesterol-lowering drugs such as statins may reduce the risk of stroke in low-risk elderly patients, a French study suggests. Find all the articles below: 2015-05-19_DailyExpress – Statins to fight against stroke deaths 2015-05-19_Reuters-Cholesterol drugs may curb strokes among low-risk older adults 2015-05-19-medscape 2015-05-20_PulseToday – Statins ‘reduced risk of stroke by 30’ News Article Pulse Today […]
The ERIAS “Computer research applied to health” emerging team from the research center U897 “Epidemiology and biostatistics” is the winner of the Practical application prize, in the Method category, awarded by an international jury of experts selected by Orange for the 2nd edition of its challenge “Data for Development” (D4D) dedicated this year to Senegal*. […]
